col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


75 Results       Page 1

 [1] 
Dynasty Publishing House: Infekcionnye bolezni
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―22 Protective effect of vaccination against measles, rubella and mumps in relation to COVID-19 N.F. Nikityuk, N.Y. Nastaeva, I.A. Khrapunova, M.P. Kostinov
2 [GO] 2024―Mar―22 Rhabdomyolysis during COVID-19 infection V.V. Shmatov, E.V. Mikhailova
3 [GO] 2024―Mar―21 Concomitant hemorrhagic fever with renal syndrome and COVID-19 D.S. Sarksyan, D.A. Kilin, M.V. Dudarev, K.M. Manakhov, V.P. Anikaev, A.A. Atamanova, V.V. Maleev
4 [GO] 2024―Mar―21 The effect of single-nucleotide polymorphisms of the blood coagulation system and folate cycle genes on the severity of the duration and outcomes of COVID-19 N.R. Yamoldinov, D.S. Sarksyan, M.V. Dudarev, O.V. Malinin, V.P. Anikaev, V.V. Maleev, et al. (+5)
5 [GO] 2024―Mar―21 Neutralizing monoclonal antibodies for treatment of COVID-19 - a role in the treatment of vulnerable categories of patients V.P. Chulanov, R.G. Shmakov, D.A. Lioznov, D.I. Abdulganieva, D.A. Valishin, V.M. Grabovsky, et al. (+8)
6 [GO] 2024―Mar―21 Epidemiological and clinical efficacy of azoximer bromide for the prevention of acute respiratory infections and COVID-19 among healthcare professionals N.I. Briko, L.Yu. Grivtsova, V.A. Korshunov, M.P. Kostinov, T.S. Saltykova
7 [GO] 2024―Mar―21 Age structure of patients with COVID-19 in epidemic dynamics of novel coronavirus infection in the Rostov Region T.I. Tverdokhlebova, A.G. Suladze, A.A. Ryndich, A.N. Matuzkova, D.V. Dontsov, F.V. Logvin
8 [GO] 2024―Mar―21 Algorithm for managing outpatients with COVID-19 infection Yu.A. Sharavina, S.V. Nikolaeva, A.N. Pestova, Zh.B. Ponezheva
9 [GO] 2024―Mar―21 Final results of an adaptive randomized open-label controlled study on the efficacy and safety of enisamium iodide for inpatient treatment of the COVID-19 infection N.Yu. Pshenichnaya, K.V. Zhdanov, D.A. Lioznov
10 [GO] 2024―Mar―21 Efficacy of Remaxol in COVID-19 patients receiving antiviral therapy А.А. Shuldyakov, E.Р. Lyapina, A.N. Smagina, O.B. Lisko, A.L. Kovalenko, E.I. Kozorez
11 [GO] 2024―Mar―21 High levels of cytokines IL-17A, IL-18, VEGF-A are biomarkers of the incompleteness of the immune inflammatory process, signaling the danger of developing postcovid syndrome in the period of COVID-19 reconvalescence V.N.Gorodin V.N.Gorodin, I.V.Nesterova I.V.Nesterova, V.A.Matushkina V.A.Matushkina, G.A.Chudilova G.A.Chudilova, V.N.Chapurina V.N.Chapurina, L.V.Lomtatidze L.V.Lomtatidze, et al. (+2)
12 [GO] 2024―Mar―21 Management strategy for virus-induced inflammation in COVID-19. Results of a multicenter, adaptive, randomized, double-blind, placebo-controlled study in outpatients O.V. Kalyuzhin, A. Baranova, M.I. Bagaeva
13 [GO] 2024―Mar―21 T-cell immune response to SARS-CoV-2 in HIV patients O.E. Pobegalova, D.A. Lioznov, T.V. Antonova, M.A. Shuklina, A.-P.S. Shurygina
14 [GO] 2024―Mar―15 Novel coronavirus infection (COVID-19) in children. Clinical observations R.Kh. Begaydarova, G.K. Alshynbekova, Kh.G. Devdariani, G.Е. Nassakayeva, A.E. Dyusembaeva, O.A. Zolotareva, et al. (+5)
15 [GO] 2024―Mar―15 Comparison of mortality in hospitalized patients with COVID-19 depending on the presence or lack of history of vaccination E.A. Karaseva, V.A. Martynov, K.A. Ageeva, S.B. Maukayeva, A.S. Romashkina, S.S. Karimova
16 [GO] 2024―Mar―15 The significance of the study of oxygen tension in urine during of acute kidney injury in patients with COVID-19 D.S. Sarksyan, M.V. Dudarev, N.R. Yamoldinov, O.V. Malinin, V.P. Anikaev, V.V. Maleev, et al. (+2)
17 [GO] 2024―Mar―15 Significance of viral load in assessment of the clinical and epidemiologic status of patients with COVID-19 A.A. Samkov, O.A. Burgasova, N.A. Kuznetsova, M.V. Chesnokova, D.A. Ogarkova, V.A. Gushchin, I.N. Tyurin
18 [GO] 2024―Mar―15 Immune correction in the outpatient treatment of COVID-19 L.R. Mukhamadieva, G.A. Mavzyutova, G.Kh. Mirsaeva, N.V. Aleksandrovich, G.F. Amirova, Z.F. Abrarova, et al. (+3)
19 [GO] 2024―Mar―15 New coronavirus infection in newborns: clinical and epidemiological features, efficacy of therapy with recombinant interferon α-2b G.P. Martynova, M.A. Stroganova, A.K. Chudakov, V.V. Malinovskaya, A.N. Shuvalov, A.B. Belkina, A.V. Karasev
20 [GO] 2023―Aug―20 Comparative characteristics of acute respiratory viral infections, influenza and COVID-19 according to the data of infectious diseases hospital in Nalchik A.R. Marzhokhova, Z.F. Kharaeva, Zh.B. Ponezheva, L.E. Balagova, M.R. Ivanova, M.Yu. Marzhokhova
21 [GO] 2023―Aug―20 GGT Level as a New Biomarker of COVID-19 Infection; a Systematic Review and Meta-Analysis Comparing Intensive Care Unit (ICU) Patients with Non-ICU Cases Masoud Tahani, Shiva Rakhshani Nasab, Iraj Shahramian, Mahdi Afshari, Hadi Mirzaei, Fateme Parooie, Morteza Salarzaei
22 [GO] 2023―Aug―20 Innovative approaches to treatment of human herpesvirus infections during the COVID-19 pandemic D.V. Isakov
23 [GO] 2023―Jul―27 Clinical and laboratory characteristic of patients with COVID-19 and meningococcal co-infection L.K. Alimova, А.А. Grishaeva, E.A. Burdakova, N.T. Shapieva, A.M. Domkina, A.N. Kruglov, Zh.B. Ponezheva
24 [GO] 2023―Jul―27 First experience of using casirivimab/imdevimab in COVID-19 in the Russian Federation P.O. Bogomolov, A.O. Bueverov, E.L. Bueverova, A.A. Кhvan, I.V. Maev, M.V. Arapova, et al. (+3)
25 [GO] 2023―Jul―27 Feasibility of targeted antiviral therapy for acute respiratory viral infections in the COVID-19 pandemic Kh.G. Omarova, L.A. Balykova, N.Yu. Pshenichnaya, D.N. Zemskov, K.Ya. Zaslavskaya, A.V. Taganov, P.A. Belyy
26 [GO] 2023―Jul―26 Effect of recombinant interferon alfa-2b on cytokine production activity of immune system cells in children with COVID-19 G.P. Martynova, A.A. Savchenko, M.A. Stroganova, Ya.A. Bogvilene, L.A. Ikkes, V.D. Belenyuk, E.O. Shavrina
27 [GO] 2023―Jul―26 Dynamics of fecal zonulin levels in COVID-19 and in the post-covid period in children A.V. Polunina, V.P. Novikova, A.E. Blinov, O.N. Varlamova, A.A. Belova, A.L. Balashov, et al. (+3)
28 [GO] 2023―Jul―26 Features of secretory immunoglobulin a in patients after COVID-19 infection A.А. Khasanova, M.P.Kostinov Kostinov, I.L. Soloveva, О.V. Kalinovskaya, E.A. Khromova, A.N. Shuvalov, T.S. Guseva
29 [GO] 2023―Jul―26 Comparing the efficacy of meglumine acridon acetate and pentanedioic acid imidazolyl ethanamide in the outpatient treatment for ARVI during the COVID-19 pandemic M.S. Savenkova, E.N. Vetrova, E.I. Isaeva, G.N. Kraseva, N.A. Abramova, M.B. Shabat, et al. (+3)
30 [GO] 2023―Mar―29 Characteristics of hypervirulent multi-drug resistant Klebsiella pneumoniae strains in inpatients with severe COVID-19 A.E. Goncharov, D.V. Azarov, A.S. Mokhov, A.A. Pochtovyi, D.D. Kustova, V.A. Gushchin, et al. (+9)
31 [GO] 2023―Mar―29 Defects in the interferon system associated with a deficiency of natural killers and T-cells in patients with COVID-19 I.V. Nesterova, V.N. Gorodin, G.A. Chudilova, V.N. Chapurina, V.A. Matushkina, L.V. Lomtatidze, et al. (+4)
32 [GO] 2023―Mar―29 Pathomorphological changes in some organs and tissues of COVID-19 convalescent patients V.G. Akimkin, O.S. Levin, A.A. Ploskireva, A.V. Gorelov, A.G. Komarova, A.S. Litvinenko, et al. (+2)
33 [GO] 2023―Mar―29 Efficacy and safety of imidazolyl ethanamide pentandioic acid for COVID-19: a multicenter, randomized, double-blind, placebo-controlled clinical trial A.V. Gorelov, A.G. Malyavin, E.A. Antonova, T.A. Pobedinskaya, А.А. Globenko, A.V. Kapashin, M.I. Bagaeva
34 [GO] 2022―Apr―15 Effects of recombinant IFN-α2b on the phenotype of neutrophil granulocyte subpopulations in patients with COVID-19 I.V. Nesterova, V.N. Gorodin, G.A.Chudilova Chudilova, V.N. Chapurina, V.A. Matushkina, R.Yu. Gabdrakhmanova, et al. (+4)
35 [GO] 2022―Apr―15 Experience in the use of biological therapy (tocilizumab) in children with severe forms of COVID-19 L.N. Mazankova, I.M. Osmanov, E.R. Samitova, M.A. Antsupova, I.I. Afukov, A.B. Malakhov, et al. (+3)
36 [GO] 2022―Apr―15 Results of RT-PCR test for the presence of SARS-CoV-2 in multiple organs of post-COVID patients who died from causes other than COVID-19 S.S. Petrikov, M.A. Godkov, A.A. Kanibolotsky, N.S. Dyakun, A.K. Shabanov, V.V. Kulabukhov, et al. (+2)
37 [GO] 2022―Apr―15 Rationale for antiepidemic measures aimed to prevent focal incidence of COVID-19 in dormitories (on the example of Moscow) A.V. Zadoroshnyy, N.Yu. Pshenichnaya, V.G. Akimkin, V.V. Maleev
38 [GO] 2022―Apr―08 Therapeutic potential of inosine pranobex in enhancing non-specific antiviral protection in patients with COVID-19 D.V. Isakov
39 [GO] 2022―Apr―08 Clinical and laboratory characteristics COVID-19 D.A. Shikhnebiev, R.M. Ragimov, Z.G. Tagirova, N.M. Abdullaeva, A.E. Muslimova
40 [GO] 2022―Apr―08 Serotonin adipate in intensive therapy of patients with severe COVID-19 M.V. Bykov, D.V. Chernyshyov, E.N. Lazareva, S.V. Krasnova, N.A. Tsvetkova, Zh.B. Ponezheva, et al. (+2)
41 [GO] 2022―Apr―08 Clinical and epidemiological significance of diarrhea in children with COVID-19 L.N. Mazankovа, S.G. Gorbunov, E.R. Samitova, I.M. Osmanov, V.G. Akimkin, A.A. Ploskireva, et al. (+2)
42 [GO] 2022―Apr―08 Efficacy of recombinant interferon α-2b in the complex therapy of COVID-19 V.V. Krasnov, A.A. Katirkina, P.G. Zubarov, A.A. Levina, G.S. Bragina, E.N. Vyzhlova
43 [GO] 2022―Apr―08 Proactive anti-inflammatory therapy with levilimab for patients with COVID-19 V.N. Gorodin, D.L. Moisova, S.V. Zotov, A.A. Vanyukov, Yu.E. Сhumakova
44 [GO] 2022―Apr―08 COVID-19 as many-faced Janus. On the classification of a new coronavirus infection A.V. Gorelov, A.A. Ploskireva, Zh.B. Ponezheva, Kh.G. Omarova, S.V. Nikolaeva, A.R. Marzhokhova, et al. (+6)
45 [GO] 2022―Apr―08 Clinical and immunological characteristics of COVID-19 associated with human herpesvirus infections: management algorithms for mixed infections G.Kh. Vikulov, I.V. Oradovskaya
46 [GO] 2022―Apr―08 COVID-19 pandemic: a new round of antibiotic resistance V.G. Akimkin, A.V. Tutelyan, N.I. Shulakova, E.M. Voronin
47 [GO] 2022―Apr―08 Factors associated with poor outcomes in pneumonia patients during the COVID-19 pandemics A.Yu. Popova, E.B. Ezhlova, Yu.V. Demina, O.E. Trotsenko, A.P. Bondarenko, T.A. Zaitseva, et al. (+5)
48 [GO] 2022―Apr―08 Current concept of cerebral dysfunction in COVID-19 patients V.V. Maleev, S.M. Vedinov, V.N. Gorodin
49 [GO] 2022―Apr―08 Persistent hiccups as a new chief complaint of patients with COVID-19: A series of four cases Iraj Shahramian, Hadi Mirzaie, Morteza Salarzaei, Fateme Parooie
50 [GO] 2022―Apr―08 Resolution of the Council of Experts. New possibilities of etiotropic therapy for coronavirus infection
51 [GO] 2022―Apr―08 Hyperechogenic signal from the pericardium after vaccination against SARS-CoV-2 Z.N. Sukmarova, Yu.V. Ovchinnikov, G.O. Gudima, F.M. Ibragimova, O.V. Afonina, K.E. Machkalyan
52 [GO] 2022―Apr―08 Effect of azoximer bromide on the severity of clinical manifestations in patients after SARS-CoV-2 infection K. Kasyanenko, O.V. Maltsev, K.V. Kozlov, K.V. Zhdanov, I.F. Seryi
53 [GO] 2022―Apr―08 Characteristics of patients with severe and extremely severe SARS-CoV-2 infection treated in the intensive care unit of Nalchik Hospital No 1 A.R. Marzhokhova, A.A. Ploskireva, Z.F. Kharaeva, M.Yu. Marzhokhova, L.E. Balagova, M.R. Ivanova, et al. (+2)
54 [GO] 2021―Sep―16 Clinical and laboratory profile of patients with COVID-19 admitted to hospital in Moscow between May and July 2020 L.V. Kolobukhina, O.A. Burgasova, L.A. Kraeva, V.A. Gushchin, E.I. Burtseva, I.S. Kruzhkova, et al. (+17)
55 [GO] 2021―Sep―16 Role of polymorphisms of genes involved in hemostasis in COVID-19 pathogenesis V.N. Gorodin, D.L. Moysova, S.V. Zotov, A.A. Vanyukov, A.A. Podsadnyaya, Yu.V. Tikhonenko
56 [GO] 2021―Sep―16 The use of interferon alpha-2b for prevention of novel coronavirus infection in healthcare workers Yu.O. Khlynina, A.A. Arova, A.B. Nevinsky
57 [GO] 2021―Jul―27 The lung-gut axis and COVID-19 V.P. Novikova, A.I. Khavkin, A.V. Polunina, A.V. Gorelov
58 [GO] 2021―Jul―27 Role of antioxidant therapy in patients with moderate and severe COVID-19 E.K. Shavarova, E.R. Cazakhmedov, M.V. Alekseeva, L.G. Ezhova, Zh.D. Kobalava
59 [GO] 2021―Jul―27 Combined oral contraceptives and treatment of new coronavirus infection (COVID-19): aspects of drug interactions O.A. Limanova, L.E. Fedotova, O.A. Gromova
60 [GO] 2021―Jul―27 Mono- and mixed respiratory tract infections in children: relevance of the problem during the COVID-19 pandemics S.V. Nikolaeva, D.V. Usenko, S.V. Shabalina, Yu.N. Khlypovka, A.V. Gorelov
61 [GO] 2021―Jul―23 Interferon alpha-2b in comprehensive treatment of patients with COVID-19 A.V. Mordyk, O.G. Ivanova, K.Yu. Samsonov, S.V. Sitnikova, L.A. Zenkova
62 [GO] 2021―Jul―23 The efficacy of intranasal recombinant interferon alpha-2b for emergency prevention of COVID-19 in healthcare workers I.V. Feldblium, M.Yu. Devyatkov, A.A. Gendler, S.M. Maltseva, T.M. Repin, V.N. Nikolenko
63 [GO] 2021―Jul―23 Epidemic process of COVID-19 in the Russian Federation: interim results. 2nd report N.Yu. Pshenichnaya, I.A. Lizinfeld, G.Yu. Zhuravlev, A.A. Ploskireva, V.G. Akimkin, A.A. Erovichenkov
64 [GO] 2021―Mar―10 The structure of seroprevalence to the SARS-CoV-2 virus among residents of the Moscow Region during the period of epidemic incidence of COVID-19 A.Yu. Popova, E.B. Ezhlova, A.A. Melnikova, O.M. Mikailova, S.Yu. Kombarova, M.A. Kostina, et al. (+20)
65 [GO] 2021―Mar―10 Collective immunity to SARS-CoV-2 of Moscow residents during the COVID-19 epidemic period A.Yu. Popova, E.B. Yezhlova, A.A. Melnikova, E.E. Andreeva, S.Yu. Kombarova, L.V. Lyalina, et al. (+18)
66 [GO] 2021―Mar―10 Socioeconomic aspects of COVID-19 on the example of Rostov region T.I. Tverdokhlebova, E.V. Kovalev, H.V. Karpushchenko, M.A. Kulak, O.S. Dumbadze, A.R. Litovko, A.S. Kaljuzhin
67 [GO] 2021―Mar―10 Evaluation of the preventive efficacy of recombinant interferon α-2b in ambulance personnel contacting with COVID-19 patients V.P. Vavilova, A.M. Vavilov, N.K. Perevoshchikova, S.A. Tsarkova
68 [GO] 2021―Mar―10 Meglumin acridonacetate to treat COVID-19: prospect of using P.V. Mazin, R.Kh. Khafisyanova, N.K. Mazina, A.L. Kovalenko, A.R. Askhadullin
69 [GO] 2020―Dec―17 Characteristics of COVID-19 and possibilities of early causal therapy. Results of favipiravir use in clinical practice L.A. Balykova, A.V. Govorov, A.O. Vasilyev, E.N. Simakina, A.S. Agafyina, A.Yu. Ivanova, et al. (+4)
70 [GO] 2020―Dec―17 Сoronavirus infection COVID-19 in children in the Russian Federation A.V. Gorelov, S.V. Nikolaeva, V.G. Akimkin
71 [GO] 2020―Dec―17 Some epidemiological aspects of the new coronavirus infection (COVID-19) in Rostov region A.R. Litovko, T.I. Tverdokhlebova, E.V. Kovalev, G.V. Karpushchenko, S.A. Nenadskaya, V.V. Agafonova, et al. (+8)
72 [GO] 2020―Dec―17 Epidemic process of COVID-19 in the Russian Federation: interim results. 1th report N.Yu. Pshenichnaya, I.A. Lizinfeld, G.Yu. Zhuravlev, А.A. Ploskireva, V.G. Akimkin
73 [GO] 2020―Dec―17 Recombinant interferons in comprehensive therapy for new coronavirus infection E.V. Melekhina, S.V. Nikolaeva, A.S. Ilyinskaya, Zh.B. Ponezheva, A.S. Akopyan, A.I. Krapivkin, et al. (+2)
74 [GO] 2020―Oct―19 Antioxidants/antihypoxants: the missing puzzle piece in effective pathogenetic therapy for COVID-19 T.A. Voronina
75 [GO] 2020―Oct―19 Use of antiseptics in respiratory infections during the COVID-19 pandemic G.Kh. Vikulov
 [1] 

75 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec